Redeye comments on Cantargia's Q2 report. CAN10 is progressing according to plan with proof-of-mecha...
Redeye comments on Verve Group’s Q2 2024 numbers, which align with preliminary figures.
EcoRub (”EcoRub” eller ”bolaget”) publicerade den 28 augusti 2024 bolagets delårsrapport för det and...
Redeye expects the Integrum share to trade down considerably during the day.
Etteplan lowered its guidance as the market conditions have remained weak.
Media keeps delivering like clockwork, 18% organic growth in Q2 We remove Platform and Sportsbook fr...
Limited estimate revisions after solid Q2 with several promising signs Base machine is working, scal...
Även om Cell impacts utveckling går långsammare än vi tidigare prognosticerat bedömer vi att Cell Im...
Loihde’s Q2 was better than estimated, profitability in particular, with adj.
Embark Group AB (”Embark” eller ”Bolaget”) fortsatte under det andra kvartalet att kapitalisera på t...
Nettoomsättningen i det andra kvartalet uppgick till 202,7 MSEK (203,9), en minskning med cirka 0,6 ...
First Venture Sweden (”First Venture” eller ”Bolaget”) är ett investmentbolag med fokus på snabbväxa...
Q2: 21% ARR growth in line, FCF of DKK -4m vs. ABGSCe DKK -6m Reiterates FY'24 guidance, as expected...
Redeye’s initial take on Xbrane’s Q2 report is that end-customer sales and profit split were higher ...
Redeye updates its view on Lifecare following the Q2 report and recent company developments, includi...
